Highbridge Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,670
| Closed | -$163K | – | 1201 |
|
|
2017
Q2 | $163K | Sell |
11,670
-23,146
| -66% | -$323K | ﹤0.01% | 759 |
|
|
2017
Q1 | $594K | Buy |
34,816
+19,139
| +122% | +$327K | 0.01% | 663 |
|
|
2016
Q4 | $161K | Buy |
15,677
+4,967
| +46% | +$51K | ﹤0.01% | 925 |
|
|
2016
Q3 | $108K | Buy |
+10,710
| New | +$108K | ﹤0.01% | 973 |
|
|
2015
Q1 | – | Sell |
-17,880
| Closed | -$238K | – | 1090 |
|
|
2014
Q4 | $238K | Buy |
+17,880
| New | +$238K | ﹤0.01% | 651 |
|